Status:
COMPLETED
Artificial Intelligence-assissted Glaucoma Evaluation
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
Chinese Academy of Sciences
Conditions:
Artificial Intelligence
Glaucoma
Eligibility:
All Genders
Brief Summary
Glaucoma is currently the second leading cause of irreversible blindness in the world. Our study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial In...
Detailed Description
Glaucoma is currently the second leading cause of irreversible blindness in the world, which brings heavy burden to human society. Compared to other ocular diseases, diagnostic process of glaucoma is ...
Eligibility Criteria
Inclusion
- BCVA\>0.1
- able to complete reliable visual field test
- no history of intraocular surgery or fundus laser
Exclusion
- 1\. unable to complete visual field test
Key Trial Info
Start Date :
August 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
10800 Patients enrolled
Trial Details
Trial ID
NCT03268031
Start Date
August 15 2017
End Date
February 1 2020
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China, 510000